Tuesday turned out to be a good day for Ocugen (OCGN) investors. Shares took off after the company disclosed that the FDA had removed the clinical hold placed on the investigational new drug (IND) app...
Tuesday turned out to be a good day for Ocugen (OCGN) investors. Shares took off after the company disclosed that the FDA had removed the clinical hold placed on the investigational new drug (IND) app...